Skip to main content

Andrea Caballero Garralda

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry
Vall Hebron Institut de Recerca
Bioquímic/a Clínic/a
Bioquímica
Cross-departmental services

Andrea Caballero Garralda

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry
Vall Hebron Institut de Recerca
Bioquímic/a Clínic/a
Bioquímica
Cross-departmental services

Projects

Estudio de la quasiespecies del gen X en ARN circulante del virus de la hepatitis B (ARN-VHB): en búsqueda de nuevos factores pronósticos y dianas para terapia génica.

IP: -
Collaborators: Lluis Castells Fusté, Andrea Caballero Garralda, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI18/01436
Duration: 01/01/2019 - 31/12/2022

Búsqueda de posibles dianas terapéuticas en la región del gen x del virus de la hepatitis B en base al estudio de conservación de dicha región mediante secuenciación masiva.

IP: -
Collaborators: Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria del Pilar Reimundo Diaz-Fierros, Andrea Caballero Garralda
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI15/00856
Duration: 01/01/2016 - 30/06/2019

Kidney and sex hormones: Novel insights into development and progression of the metabolic syndrome

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin, Concepció Jacobs Cachá, Andrea Caballero Garralda
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 266200
Reference: SAF2011-29506
Duration: 01/01/2012 - 31/12/2014

Ministerio de Ciencia

Prevalencia de las quasispecies mutantes en antígeno de superficie en paceintes con hepatitis crónica B y trasplantados por hepatitis B

IP: Maria Buti Ferret
Collaborators: Andrea Caballero Garralda, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 275715.44
Reference: PI11/01973
Duration: 01/01/2012 - 28/02/2015

Related news

The team was born from the union of the Clinical Biochemistry and the Drug Delivery and Targeting groups with the aim of improving the diagnostic and prognostic process and developing new therapeutic strategies.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Els ajuts impulsaran estudis en els camps del VIH, les hepatitis virals i la COVID-19.

Related professionals

Victor Monforte Torres

Victor Monforte Torres

Main researcher
Pneumology
Read more
Blanca Joseph Mullol

Blanca Joseph Mullol

Research technician
Rheumatology
Read more
Cristina Aguilar Riera

Cristina Aguilar Riera

Growth and Development
Read more
Montserrat Fabregat Garcia

Montserrat Fabregat Garcia

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.